BETHESDA, Md., Jan. 17, 2025 /PRNewswire/ — The Association for the Advancement of Blood & Biotherapies (AABB) will host a congressional briefing on Jan. 28 to educate policymakers on the life-saving role of blood transfusions and biotherapies. The briefing will spotlight challenges and opportunities in blood banking, transfusion medicine and biotherapies.
The briefing, “Advancing Blood, Transfusion Medicine and Biotherapies: From Donor to Patient. From Lab to Bedside,” will take place from 1:30 to 2:45 p.m. at the Rayburn House Office Building (Room 2168) in Washington, D.C.
This event will feature AABB leaders and expert voices in the field, including:
- Debra BenAvram, FASAE, CAE, chief executive officer, AABB.
- Meghan Delaney, DO, MPH, chief, division of pathology & laboratory medicine, Children’s National Hospital.
- Nancy Dunbar, MD, medical director, blood bank and special coagulation laboratory, Dartmouth-Hitchcock Medical Center.
- Delisa English, MBA, chief executive officer, The Blood Connection.
- Ray Goodrich, PhD, professor, Colorado State …